First-In-Class PreHistin Could Challenge Antihistamines In Two Years – Exec
This article was originally published in The Pink Sheet Daily
Executive Summary
Irvine, Calif.-based Cobalis, which has patent for using cyanocobalamin to treat Immunoglobulin E-mediated allergic diseases, expects NDA submission in Q3 2007.
You may also be interested in...
Avanir Abreva Cold Sore/Fever Blister Cream Approved By FDA
Avanir Pharmaceuticals' 10% docosanol cream was approved July 25 for the treatment of cold sores and fever blisters. The product, which FDA's approval letter indicates will be marketed as Abreva Cream, will be the first FDA-approved OTC cold sore and fever blister treatment.
Blame China? Experts Advise Congress, Industry Take A Wider View
The global scope of food safety is becoming apparent, and recent problems with products imported from China are but a part of U.S. food safety concerns, industry experts say
Blame China? Experts Advise Congress, Industry Take A Wider View
The global scope of food safety is becoming apparent, and recent problems with products imported from China are but a part of U.S. food safety concerns, industry experts say